Project Details
Project Description
| Status | Finished |
|---|---|
| Effective start/end date | 29/02/24 → 27/02/26 |
Keywords
- Clinical Trials
- 219867
- GSK4527226
Clinical Trial Phase
- Phase II
A Phase 2, Parallel Group, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Multicenter Treatment Study to Evaluate the Efficacy and Safety of GSK4527226 [AL101] Intravenous Infusion Compared with Placebo in Patients with Early Alzheimer’s Disease
- Darby, David (Primary Chief Investigator (PCI))
Project: Research